Yanki Yarman: Linking Genetic Variants to Clinical Outcomes in Thrombosis
Yanki Yarman, MD and Ph.D. Student at Sidney Kimmel Medical College, shared a post on LinkedIn about a recent article by Marvin T. Nieman, published in ASH, adding:
“I’m truly touched and honored by this Blood commentary penned by Dr. Marvin Nieman on my PhD project.
I’m especially grateful for his description of our study and its comprehensive methods ‘as a model for future studies aiming to connect genetic variants with molecular mechanisms and clinical outcomes.’
As a physician-scientist in training, I care deeply about genetically screening patients and understanding the molecular pathways underlying their diseases.
I hope to practice personalized medicine in the near future.
Here’s the Blood commentary on the GRK5 variant that we linked to increased thrombotic risk.”
Title: GRK5 polymorphism turns up the volume on PAR1
Auhtors: Marvin Nieman
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience